Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Ocugen (OCGN) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Ocugen (OCGN) over the last 13 years, with Q3 2025 value amounting to $304.0 million.

  • Ocugen's Shares Outstanding (Weighted Average) rose 928.62% to $304.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $304.0 million, marking a year-over-year increase of 928.62%. This contributed to the annual value of $271.0 million for FY2024, which is 1091.49% up from last year.
  • According to the latest figures from Q3 2025, Ocugen's Shares Outstanding (Weighted Average) is $304.0 million, which was up 928.62% from $292.1 million recorded in Q2 2025.
  • Ocugen's Shares Outstanding (Weighted Average)'s 5-year high stood at $304.0 million during Q3 2025, with a 5-year trough of $186.3 million in Q1 2021.
  • Its 5-year average for Shares Outstanding (Weighted Average) is $239.2 million, with a median of $238.3 million in 2023.
  • As far as peak fluctuations go, Ocugen's Shares Outstanding (Weighted Average) skyrocketed by 25399.57% in 2021, and later soared by 799.05% in 2024.
  • Ocugen's Shares Outstanding (Weighted Average) (Quarter) stood at $195.0 million in 2021, then grew by 10.04% to $214.6 million in 2022, then rose by 13.85% to $244.3 million in 2023, then rose by 10.91% to $271.0 million in 2024, then rose by 12.18% to $304.0 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $304.0 million in Q3 2025, compared to $292.1 million in Q2 2025 and $292.0 million in Q1 2025.